Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Feith

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 15, 2011
Carcinogenesis studies in mice with genetically engineered alterations in polyamine metabolismDavid J Feith
Cancer Growth and Metastasis|September 19, 2015
Skin Carcinogenesis Studies Using Mouse Models with Altered PolyaminesShannon L Nowotarski, David J Feith, Lisa M Shantz
Cancer Research|July 23, 2003
Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesisLouise Y Y Fong, David J Feith, Anthony E Pegg
Carcinogenesis|December 11, 2012
Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient miceDavid J Feith, Anthony E Pegg, Louise Y Y Fong
Expert Opinion on Therapeutic Targets|April 25, 2017
The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemiaSu-Fern Tan, Jennifer M Pearson, David J Feith, et al.
Ejhaem|August 9, 2022
LGL leukemia patients exhibit substantial protective humoral responses following SARS-CoV-2 vaccinationHeejin Cheon, Omar Elghawy, Bryna C Shemo, et al.
Carcinogenesis|January 10, 2006
Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesisDavid J Feith, Sofia Origanti, Paula L Shoop, et al.
Journal of Molecular Biology|October 8, 2013
Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferationIngo Lange, Dirk Geerts, David J Feith, et al.
Leukemia Research Reports|February 25, 2015
Emergence of a STAT3 mutated NK clone in LGL leukemiaYiyi Yan, Thomas L Olson, Susan B Nyland, et al.
European Journal of Haematology|October 16, 2016
Vitamin D in hematological disorders and malignanciesPaige M Kulling, Kristine C Olson, Thomas L Olson, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Methods in Molecular Biology (Clifton, N.J.)|February 15, 2011
Carcinogenesis studies in mice with genetically engineered alterations in polyamine metabolismDavid J Feith
Cancer Growth and Metastasis|September 19, 2015
Skin Carcinogenesis Studies Using Mouse Models with Altered PolyaminesShannon L Nowotarski, David J Feith, Lisa M Shantz
Cancer Research|July 23, 2003
Antizyme overexpression in transgenic mice reduces cell proliferation, increases apoptosis, and reduces N-nitrosomethylbenzylamine-induced forestomach carcinogenesisLouise Y Y Fong, David J Feith, Anthony E Pegg
Carcinogenesis|December 11, 2012
Targeted expression of ornithine decarboxylase antizyme prevents upper aerodigestive tract carcinogenesis in p53-deficient miceDavid J Feith, Anthony E Pegg, Louise Y Y Fong
Expert Opinion on Therapeutic Targets|April 25, 2017
The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemiaSu-Fern Tan, Jennifer M Pearson, David J Feith, et al.
Ejhaem|August 9, 2022
LGL leukemia patients exhibit substantial protective humoral responses following SARS-CoV-2 vaccinationHeejin Cheon, Omar Elghawy, Bryna C Shemo, et al.
Carcinogenesis|January 10, 2006
Tumor suppressor activity of ODC antizyme in MEK-driven skin tumorigenesisDavid J Feith, Sofia Origanti, Paula L Shoop, et al.
Journal of Molecular Biology|October 8, 2013
Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferationIngo Lange, Dirk Geerts, David J Feith, et al.
Leukemia Research Reports|February 25, 2015
Emergence of a STAT3 mutated NK clone in LGL leukemiaYiyi Yan, Thomas L Olson, Susan B Nyland, et al.
European Journal of Haematology|October 16, 2016
Vitamin D in hematological disorders and malignanciesPaige M Kulling, Kristine C Olson, Thomas L Olson, et al.
Pageof 8